We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov Menu

Improved ICU Outcomes With Protocolized Management of Analgesia, Sedation and Delirium

This study has been completed.
ClinicalTrials.gov Identifier:
First Posted: July 25, 2007
Last Update Posted: July 25, 2007
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Maisonneuve-Rosemont Hospital
To assess pain, agitation, and delirium experienced by critically ill patients daily and evaluate the impact of a protocol; to compare the incidence of coma and delirium, length of stay, mortality and costs of care between pre- and post-protocol groups.

Condition Intervention
Critical Care Other: protocol

Study Type: Observational
Study Design: Observational Model: Defined Population
Observational Model: Natural History
Time Perspective: Longitudinal
Time Perspective: Retrospective/Prospective
Official Title: Comparison of no Protocol vs Protocolized Approach to Pain, Sedation and Delirium Management in the ICU

Resource links provided by NLM:

Further study details as provided by Maisonneuve-Rosemont Hospital:

Enrollment: 1214
Study Start Date: August 2003
Study Completion Date: November 2005
Intervention Details:
    Other: protocol
    management protocols of non-pharmacological strategies and individualized titration of analgesics, sedatives, and anti-psychotics based on observed scores to manage sedation, analgesia and delirium.

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • All adult patients admitted to ICU

Exclusion Criteria:

  • Repeat admission within the same hospitalisation; moribund patients
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00506649

Canada, Quebec
Hopital Maisonneuve Rosemont
Montreal, Quebec, Canada, H1T 2M4
Sponsors and Collaborators
Maisonneuve-Rosemont Hospital
Principal Investigator: Yoanna Skrobik, MD FRCP(c) Maisonneuve-Rosemont Hospital
  More Information

ClinicalTrials.gov Identifier: NCT00506649     History of Changes
Other Study ID Numbers: 007
First Submitted: July 23, 2007
First Posted: July 25, 2007
Last Update Posted: July 25, 2007
Last Verified: July 2007

Keywords provided by Maisonneuve-Rosemont Hospital:

Additional relevant MeSH terms:
Neurobehavioral Manifestations
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms
Neurocognitive Disorders
Mental Disorders